Cost-effectiveness analysis of carrier and prenatal genetic testing for X-linked hemophilia

Meng Che Tsai, Chao Neng Cheng, Ru Jay Wang, Kow Tong Chen, Mei Chin Kuo, Shio Jean Lin

研究成果: Article同行評審

6 引文 斯高帕斯(Scopus)


Background/purpose: Hemophilia involves a lifelong burden from the perspective of the patient and the entire healthcare system. Advances in genetic testing provide valuable information to hemophilia-affected families for family planning. The aim of this study was to analyze the cost-effectiveness of carrier and prenatal genetic testing in the health-economic framework in Taiwan. Methods: A questionnaire was developed to assess the attitudes towards genetic testing for hemophilia. We modeled clinical outcomes of the proposed testing scheme by using the decision tree method. Incremental cost-effectiveness analysis was conducted, based on data from the National Health Insurance (NHI) database and a questionnaire survey. Results: From the NHI database, 1111 hemophilic patients were identified and required an average medical expenditure of approximately New Taiwan (NT) $2.1 million per patient-year in 2009. By using the decision tree model, we estimated that 26 potential carriers need to be tested to prevent one case of hemophilia. At a screening rate of 79%, carrier and prenatal genetic testing would cost NT $85.9 million, which would be offset by an incremental saving of NT $203 million per year by preventing 96 cases of hemophilia. Assuming that the life expectancy for hemophilic patients is 70 years, genetic testing could further save NT $14.2 billion. Higher screening rates would increase the savings for healthcare resources. Conclusion: Carrier and prenatal genetic testing for hemophilia is a cost-effective investment in healthcare allocation. A case management system should be integrated in the current practice to facilitate patient care (e.g., collecting family pedigrees and providing genetic counseling).

頁(從 - 到)722-728
期刊Journal of the Formosan Medical Association
出版狀態Published - 2015 八月 1

All Science Journal Classification (ASJC) codes

  • 醫藥 (全部)


深入研究「Cost-effectiveness analysis of carrier and prenatal genetic testing for X-linked hemophilia」主題。共同形成了獨特的指紋。